AstraZeneca Archives - Express Pharma

AstraZeneca’s Trastuzumab deruxtecan therapy receives CDSCO nod to manage HER2- low & ultra-low breast cancer in India

Pharma M&A deal value surges by 101% in Q1 2025 despite US political turbulence

PHARMAP 2025 brings together global pharma leaders to discuss innovation and drug safety

LuNGS Alliance launches free lung NGS biomarker testing for lung cancer patients in India

Cell and gene therapy market set to grow at 44% CAGR through 2030: GlobalData

AstraZeneca to invest $2.5 bn in new R&D centre, biotech agreements and manufacturing in Beijing

AstraZeneca to acquire EsoBiotec to advance cell therapy ambition

CDMO Live 2025 to spotlight the future of pharmaceutical outsourcing in Europe

Targeted therapies and improved diagnostics remain needs unmet in T2-low asthma

Respiratory syncytial virus prophylactic market to surpass $6 bn across 8MM in 2030